首页> 外文OA文献 >The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma

【2h】

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma

机译：组蛋白脱乙酰化酶抑制剂Panobinostat是犬弥漫性大B细胞淋巴瘤的有效抗肿瘤剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Joana N.R. Dias; Sandra I. Aguiar; Diane M. Pereira; Ana S. André; Lurdes Gano; João D.G. Correia; Belmira Carrapiço; Barbara Rütgen; Rui Malhó; Conceição Peleteiro; João Goncalves; Cecília M.P. Rodrigues; Solange Gil; Luís Tavares; Frederico Aires-da-Silva;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Triplet Therapy with PD-1 Blockade, Histone Deacetylase Inhibitor, and DNA Methyltransferase Inhibitor Achieves Radiological Response in Refractory Double-Expressor Diffuse Large B-cell Lymphoma with 17p Deletion [J] . Runhui Zheng, Xiaobo Chen, Chunyan Wang, Case Reports in Hematology . 2020,第1期

机译：具有PD-1阻断，组蛋白脱乙酰酶抑制剂和DNA甲基转移酶抑制剂的三联体疗法在难治性双脑膜弥漫性大B细胞淋巴瘤中实现了17p缺失的放射性反应
2. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents [J] . Rui Xie, Yan Li, Pingwah Tang, European Journal of Medicinal Chemistry: Chimie Therapeutique . 2018,第期

机译：含有二硫代氨基甲酸酯部分的新型2-氨基苯甲酰胺的设计，合成和生物学评价为组蛋白脱乙酰酶抑制剂和有效抗肿瘤剂
3. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents [J] . Xie Rui, Yao Yue, Tang Pingwah, European Journal of Medicinal Chemistry: Chimie Therapeutique . 2017,第期

机译：新羟肟酸盐和2-氨基苯甲酰胺的设计，合成和生物学评价为有效的组蛋白脱乙酰酶抑制剂和抗肿瘤剂
4. Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma [C] . Bohua Li, Hao Wang, Yajun Guo, International conference of molecular simulations and applied informatics technologies . 2012

机译：具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
5. Elucidation of the Mechanisms of Resistance and Sensitivity to Histone Deacetylase Inhibitor, PXD101, in Diffuse Large B-cell Lymphoma (DLBCL). [D] . Tula-Sanchez, Ana Alejandra. 2013

机译：阐明弥漫性大B细胞淋巴瘤（DLBCL）中对组蛋白脱乙酰基酶抑制剂PXD101的耐药性和敏感性机制。
6. The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma [O] . Joana N.R. Dias, Sandra I. Aguiar, Diane M. Pereira, 2018

机译：组蛋白脱乙酰基酶抑制剂panobinostat是犬弥漫性大B细胞淋巴瘤的有效抗肿瘤药
7. Anti-Cancer Effects of CKD-581, a Potent Histone Deacetylase Inhibitor against Diffuse Large B-Cell Lymphoma [O] . Soo Jin Kim, U Ji Kim, Hae Yong Yoo, 2020

机译：CKD-581的抗癌作用，一种有效的组蛋白脱乙酰酶抑制剂对弥漫性大B细胞淋巴瘤

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅